Literature DB >> 1370096

Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor.

D G Miller1, A D Miller.   

Abstract

Chinese hamster ovary (CHO) cells are resistant to infection by all of the major classes of murine retroviruses and are partially resistant to infection by gibbon ape leukemia virus. Treatment of CHO cells with the glycosylation inhibitor tunicamycin rendered these cells susceptible to infection by retroviral vectors with ecotropic, xenotropic, and amphotropic host ranges and increased the titer of gibbon ape leukemia virus pseudotyped vectors 10-fold. Vectors having a polytropic host range did not infect CHO cells in the presence or absence of tunicamycin, showing that the effect of tunicamycin was specific and related to the pseudotype of the vector. We present evidence for three mechanisms of resistance to infection: lack of viral receptors on CHO cells, the presence of nonfunctional receptors which can be made functional by treatment with tunicamycin, and the secretion of a protein factor that blocks retroviral infection of CHO cells. Several criteria indicate that the secreted inhibitor is not an interferon, and secretion of this factor was not detected in several other cell lines that were examined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370096      PMCID: PMC238262     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Transformation of mammalian cells by avian myelocytomatosis virus and avian erythroblastosis virus.

Authors:  K Quade
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

2.  Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges.

Authors:  C M Lynch; A D Miller
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.

Authors:  M A Bender; T D Palmer; R E Gelinas; A D Miller
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Genetics of somatic mammalian cells, VII. Induction and isolation of nutritional mutants in Chinese hamster cells.

Authors:  F T Kao; T T Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1968-08       Impact factor: 11.205

5.  Inhibitors of glycosylation reverse retroviral interference.

Authors:  A Rein; A M Schultz; J P Bader; R H Bassin
Journal:  Virology       Date:  1982-05       Impact factor: 3.616

6.  Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells.

Authors:  C M Corsaro; M L Pearson
Journal:  Somatic Cell Genet       Date:  1981-09

7.  Endogenous origin of defective retroviruslike particles from a recombinant Chinese hamster ovary cell line.

Authors:  K P Anderson; M A Low; Y S Lie; G A Keller; M Dinowitz
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

8.  A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection.

Authors:  L M Albritton; L Tseng; D Scadden; J M Cunningham
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

9.  Inducible expression of amplified human beta interferon genes in CHO cells.

Authors:  F McCormick; M Trahey; M Innis; B Dieckmann; G Ringold
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

10.  Mammalian cells in culture frequently release type C viruses.

Authors:  M M Lieber; R E Benveniste; D M Livingston; G J Todaro
Journal:  Science       Date:  1973-10-05       Impact factor: 47.728

View more
  60 in total

1.  Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus.

Authors:  H Miletic; M Bruns; K Tsiakas; B Vogt; R Rezai; C Baum; K Kühlke; F L Cosset; W Ostertag; H Lother; D von Laer
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 2.  Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

Authors:  J Overbaugh; A D Miller; M V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

3.  Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptor.

Authors:  C Salaün; P Rodrigues; J M Heard
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Capillary endothelial cell tropism of PVC-211 murine leukemia virus and its application for gene transduction.

Authors:  M Masuda; C A Hanson; N V Dugger; D S Robbins; S G Wilt; S K Ruscetti; P M Hoffman
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Sodium-dependent neutral amino acid transporter type 1 is an auxiliary receptor for baboon endogenous retrovirus.

Authors:  M Marin; C S Tailor; A Nouri; D Kabat
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus.

Authors:  J Y Han; P M Cannon; K M Lai; Y Zhao; M V Eiden; W F Anderson
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Properties of a unique form of the murine amphotropic leukemia virus receptor expressed on hamster cells.

Authors:  C A Wilson; K B Farrell; M V Eiden
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  A family of retroviruses that utilize related phosphate transporters for cell entry.

Authors:  D G Miller; A D Miller
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction.

Authors:  J L Battini; J E Rasko; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 10.  Murine endogenous retroviruses.

Authors:  C Stocking; C A Kozak
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.